Preston Klassen
President at REGULUS THERAPEUTICS INC.
Net worth: 770 953 $ as of 2023-05-30
Profile
Dr. Preston S.
Klassen, MD, is a President, Director & Head-Research & Development at Regulus Therapeutics, Inc. He is on the Board of Directors at Regulus Therapeutics, Inc. Dr. Klassen was previously employed as a President & Chief Operating Officer by Zura Bio Ltd., a President, Chief Executive Officer & Director by Metacrine, Inc., a Chief Medical Officer, Executive VP, Head-R&D by Arena Pharmaceuticals, Inc., a President & Chief Marketing Officer by Sanifit, Inc., a Chief Medical Officer by Laboratoris Sanifit SL, an Independent Director by Conatus Pharmaceuticals, Inc., an Executive VP & Head-Global Development by Orexigen Therapeutics, Inc., and an Executive Director-Medical by Amgen, Inc. He also served on the board at Equillium, Inc., Corvidia Therapeutics, Inc. and Chinook Therapeutics, Inc. /Old/.
He received his undergraduate degree from Central College, a graduate degree from Duke University and a doctorate degree from the University of Nebraska Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
METACRINE INC
3.25% | 2023-03-22 | 1,384,116 ( 3.25% ) | 770 953 $ | 2023-05-30 |
| 2024-01-11 | 0 ( -.--% ) | - $ | 2024-04-29 |
Preston Klassen active positions
| Companies | Position | Start |
|---|---|---|
| REGULUS THERAPEUTICS INC. | President | 2023-06-21 |
Former positions of Preston Klassen
| Companies | Position | End |
|---|---|---|
| ZURA BIO LIMITED | President | 2023-04-10 |
| METACRINE, INC. | Chief Executive Officer | 2023-01-31 |
| ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2020-06-08 |
| HISTOGEN INC. | Director/Board Member | 2020-04-30 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | President | 2017-02-28 |
Training of Preston Klassen
| University of Nebraska Medical Center | Doctorate Degree |
| Duke University | Graduate Degree |
| Central College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| REGULUS THERAPEUTICS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Sanifit, Inc.
 Sanifit, Inc. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., Sanifit, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in San Diego, CA. | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
Chinook Therapeutics, Inc. /Old/
 Chinook Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Chinook Therapeutics, Inc operates as a biotechnology company, which engages in the development of medicines for kidney diseases. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Stock Market
- Insiders
- Preston Klassen
